Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Abstract
Hypertrophic cardiomyopathies (HCM) result from distinct single-point mutations in sarcomeric proteins that lead to muscle hypercontractility. While different models
Origin : Files produced by the author(s)